Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-24

Clinical Trial Update: Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

View source ↗

Summary

A clinical trial testing adherence to treatment with a fixed-dose combination of perindopril, indapamide, and amlodipine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perindopril/Indapamide/Amlodipine fixed-dose combination (perindopril/indapamide/amlodipine)

Snippet

Sponsor: Servier Hellas Pharmaceuticals Ltd. | Conditions: Adherence to Medication Regime, Hypertensive Disease | Status: COMPLETED